VIR

Vir Biotechnology, Inc.

Biotechnology · Biotechnology

$251.53 sample

-1.49 (-0.59%) 1D

Market cap

$1.12T

Price as of

2026-10-15

Latest filing

8-K · 2026-10-02

Alerts

8

Price$251.53 +12.56% 3M daily closessample

253.04215.04

2026-07-202026-08-112026-09-022026-09-232026-10-15

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Oct 08INSInsider buy: Chief Financial Officer
Oct 02SECDEF 14A filed
Sep 23INSInsider buy: 10% owner
Sep 15SEC10-Q filed
Sep 08INSInsider buy: Director
Sep 02INSInsider buy: General Counsel
Aug 28INSInsider sell: General Counsel
Aug 24INSInsider buy: EVP, Operations

Sign up to see the real VIR record →

Company facts

SEC EDGAR registration

Name: Vir Biotechnology, Inc.
Sector: Biotechnology
Industry: Biotechnology
Smart-money score: +54sample, -100 to +100
Reporting currency: USD

Who is positioning in VIR

sample

Insiders: 34 insider transactions over 90 days, net selling, $869.5M
Congress: No member trades over 90 days
Institutions · 13F: 23 funds hold $10.4B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$66.9B +16.8% y/y

Q4 2024Q3 2026

Inventory$40.6B +7.2% y/y

Q4 2024Q3 2026

Accounts receivable$29.8B +10.9% y/y

Q4 2024Q3 2026

Total debt$83.7B +14.9% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $319.5B +6.0% 3M
Sample peer B: $284.5B +16.3% 3M
Sample peer C: $534.0B -8.9% 3M
Sample peer D: $305.7B +0.1% 3M
Sample peer E: $1.09T +1.8% 3M